Together, these findings demonstrate that ERG contributes to leukemic maintenance in IKZF1-deficient B-ALL and highlight its potential as a lineage-restricted therapeutic vulnerability. This evidence concerns the gene IKZF1 and precursor B-cell acute lymphoblastic leukemia.